| Fund ID | 805-7684768136 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 11% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 5% |
| Fund | Type | Gross assets |
|---|---|---|
| Mw Americas Tops Long-Only Fund LP | Hedge | $2.72B |
| Marshall Wace Investment Strategies - Tops US Equities Fund | Hedge | $1.82B |
| Marshall Wace Funds LP - Mw Tops US Equities (US) Fund | Hedge | $1.2B |
Mw Xo Health Innovations Fund II, LP reports $55.8 million in gross assets, among the top 52% of private funds by size.
The stated minimum investment is $1 million.
Mw Xo Health Innovations Fund II, LP is managed by Marshall Wace North America L.P.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.